Background/Aims: Pancreatic pseudocyst is a common complication of acute and chronic pancreatitis. Endoscopy ultrasound (EUS)-guided drainage includes multiple steps and requires many resources such as a linear echoendoscope and a fluoroscopy room, which may not be available at all medical centers. We aimed to evaluate the efficacy and safety of EUS-guided pancreatic pseudocyst drainage without fluoroscopy. Methods: This retrospective study analyzed 10 patients who had undergone EUSguided transmural drainage of pancreatic pseudocyst without use of fluoroscopy at the Pusan National University Hospital between January 2009 and December 2016. Drainage was performed via a transgastric approach and one or two 7 Fr double-pigtail stents were inserted. Results: The technical success rate was 100% and the clinical success rate was 80%. In two patients, clinical success was not achieved and additional percutaneous catheter drainage was done. Therefore, pseudocysts in all the patients were treated successfully without surgical drainage. However, there were three adverse events in three patients: bleeding, infection, and stent migration in each respective patient. During the median follow-up period of 36.5 months, there was no recurrence of pseudocysts in any of the patients. Conclusions: EUS-guided transmural drainage of pseudocyst drainage without use of fluoroscopy is a technically feasible, safe, and effective procedure for the treatment of pancreatic pseudocyst. Korean J Pancreas Biliary Tract 2018;23(1):24-31 
INTRODUCTION
Pancreatic pseudocyst is a common complication of acute and chronic pancreatitis. The incidence of pancreatic pseudocyst in acute pancreatitis is 5-16%, 20-40% in chronic pancreatitis. [1] [2] [3] A majority of pseudocysts associated with acute pancreatitis resolves spontaneously within 4-6 weeks of onset. 4, 5 However, pseudocysts caused by chronic pancreatitis resolve spontaneously only in about 10% of the cases. 6 The unresolved pseudocyst may be asymptomatic or may lead to epigastric pain, fever, or obstruction of the biliary tract or gastric outlet. Symptomatic and long-term unresolved pseudocyst are common indications for treatment.
In the past, surgical drainage had been the standard treatment for pancreatic pseudocysts, but endoscopic drainage is the go-to treatment these days. Since use of endoscopic ultrasound (EUS)-guidance in transmural drainage of the pancreatic pseudocysts, it has become possible to treat nonbulging pseudocysts without surgical drainage. EUS-guided transmural drainage has many advantages such as better short-and long-term prognoses, lower cost, shorter hospital stay, and improved quality of life when compared with the surgical drainage. 7 Generally, EUS-guided transmural drainage needs multiple steps and many resources such as a linear echoendoscope and a fluoroscopy room. Therefore, it would be more efficient if the number of steps for EUS-guided transmural drainage is to be minimized and use fewer resources, while maintaining the efficacy and patient safety of the procedure.
In most most of previous studies, fluoroscopy was used to confirm the location of the appropriate guidewire coiling in a pseudocyst. However, a few reports have showed successful EUS-guide pseudocyst drainage without fluoroscopy.
8-11
Most hospitals do not have a special endoscopic room that can be accessible to fluoroscopy and EUS simultaneously; therefore, the EUS equipment needs to be transferred to fluoroscopy room when necessary. If the procedure could be performed without fluoroscopy, the logistics becomes simpler and both the patient and endoscopist can avoid radiation exposure. In this study, the efficacy and safety of EUSguided transmural drainage of pancreatic pseudocyst without use of fluoroscopy were evaluated. after evaluation of the target lesion, circumambient organs, vessels, and appropriate puncture site which was less than 1 cm length between the cyst and the endoscope using EUS and endoscopy, the appropriate site for drainage was confirmed using a linear echoendoscope (GF-UCT2000; Olympus, Tokyo, Japan for insertion of the balloon dilator, additional puncture and widening of the fistula tract was performed using a needle knife (MTW-Endoskopie, Wesel, Germany). Then, the fistula was dilated with a 6-10 mm wire-guided Hurricane balloon dilator (Microvasive; Boston Scientific). One or two 7
METHODS
Fr double-pigtail stents (C-Flex™ Double Pigtail Biliary Stent; Boston Scientific) were placed across the fistula at the discretion of the endoscopist. Finally, the endoscopist confirmed the location of the plastic stent(s) by using EUS.
Technical success was defined as appropriate placement of 
DISCUSSION
Since EUS-guided transmural drainage of pancreatic pseudocyst drainage was first reported in 1992, 13 it has become a standard treatment modality rather than percutaneous or surgical methods. 7 Although EUS-guided transmural drainage of pancreatic pseudocyst is generally performed under fluoroscopic guidance, it does not essentially require the guidance since experienced endoscopists can perform needle puncturing and stent insertion under endoscopic and EUS guidance without fluoroscopic assistance. 8 In the present study, we reviewed the data of 10 cases of EUS-guided pseudocyst drainage without fluoroscopic assistance. The technical success rate was 100% and the clinical success rate was 80%. Clinical success was not achieved in two patients and additional percutaneous catheter drainage was done. As a result, complete resolution was achieved without surgical drainage in all the patients.
Single-step EUS-guided transmural drainage was introduced in 1998, and several studies have showed that this simplified method has better success rate and efficacy than the previously used EUS-guided method. this method are limited. [8] [9] [10] [11] 16 In the present study, the rates of technical success and adverse events of EUS-guided pseudocyst drainage without fluoroscopy was 100% and 30%, respectively. These results are similar to the results of previous studies regarding EUSguided pseudocyst drainage without fluoroscopy (a technical success rate of 80-100% and a complication rate of 0-30%). [8] [9] [10] [11] 16 In the present study, adverse events (bleeding, infection, and stent migration) occurred in 3 patients. Because bleeding, infection, and stent migration were related to the endoscopic drainage itself, these adverse events were not associated with the procedure without fluoroscopy. In fact, clinical outcomes of the procedure without fluoroscopy are similar to those of the procedure with fluoroscopy (a technical success rate of 89-100% and benefit rate of 0-52%). 11, 12, [17] [18] [19] The main benefit of fluoroscopy in the pseudocyst drainage is adjustment of the position of guidewire and the stents.
therefore, the displacement of the plastic stent into the gut or pseudocyst, or outside of the pseudocyst can occur more frequently in the procedure without fluoroscopy compared with the procedure with fluoroscopy. It is important whether the inserted guidewire is coiled properly, which could be confirmed with EUS in our study. Therefore, we inserted the guidewire and then predicted the coiling state through the length of the guidewire and resistance during insertion as in other studies of non-fluoroscopy procedure. 8, 20, 21 According to Rana et al., 20 when the guidewire was inserted slowly under 10 cm in length, they did not experience perforation due to the guidewire. If endoscopists can be extra careful in placing the stents into the pseudocyst, the displacement of the stent during the procedure can be avoided. In fact, there was no stent displacement during the procedure in the present study. However, it is reported that the risk factors of adverse events by non-fluoroscopy procedure are thick cystic wall and a small diameter (<6 cm) of the pseudocyst. 9 Recently, there have been cases of self-expandable metal stent (SEMS) insertion for necrosectomy or drainage of material debris. [22] [23] [24] When deploying SEMS, metal stents are better seen on EUS than plastic stents; it is possible to check if the distal end of stent is expanded during EUS guidance and the proximal end is expanded during endoscopic guidance. 22 Although not performed in this study, insertion of SEMS without fluoroscopy would be available. Further studies about this procedure will be needed.
In the present study, there was no recurrence of pseudocyst due to incomplete treatment of the pseudocyst during the median follow-up period of 36.5 months. Two patients experienced recurrence of pseudocyst 26 months and 49 months later, which was caused by another episode of alcohol-induced pancreatitis; both did not need an additional procedure. Similarly, in previous studies, the rate of recurrence of pseudocyst was low (0-11.7%) and those cases improved without additional surgical treatment. [8] [9] [10] This study has several limitations. First, this study was a retrospective, single-center study, and the number of cases was too small to draw conclusions. Secondly, all EUS-guided pseudocyst drainage included in the study were performed via the transgastric route. Transduodenal route is more difficult to perform due to the angulation of the echoendoscope, and a previous study showed that the success rate of pseudocyst drainage decreased if the pseudocyst was located in the pancreatic head. 12 Therefore, the results might have been different if this study had included cases that required the transduodenal route.
In conclusion, EUS-guided transmural drainage of pan- 
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